17 insiders reported 98 Form 4 transactions for Emergent BioSolutions Inc. (EBS) over the past 18 months (most recent 2026-07-02). Recent activity: Williams Paul Anthony (SVP, Products Business) Sell 3,000 shares, LINDAHL RICHARD S (EVP, Chief Financial Officer) Sell 3,964 shares, Glessner Coleen (EVP, Quality & Ethics, and CPL) Sell 2,018 shares, Williams Paul Anthony (SVP, Products Business) Sell 694 shares, Hartzel William (SVP, Bioservices) Sell 1,741 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-07-02 | Williams Paul Anthony | SVP, Products Business | Sell | 3,000 | $25,200 |
| 2026-06-10 | LINDAHL RICHARD S | EVP, Chief Financial Officer | Sell | 3,964 | $31,712 |
| 2026-06-10 | Glessner Coleen | EVP, Quality & Ethics, and CPL | Sell | 2,018 | $16,144 |
| 2026-06-10 | Williams Paul Anthony | SVP, Products Business | Sell | 694 | $5,552 |
| 2026-06-10 | Hartzel William | SVP, Bioservices | Sell | 1,741 | $13,928 |
| 2026-05-04 | DeGolyer Donald W | Director | Buy | 25,344 | $0 |
| 2026-05-04 | Katkin Keith | Director | Buy | 25,344 | $0 |
| 2026-05-04 | Richard Ronald | Director | Buy | 25,344 | $0 |
| 2026-05-04 | Harsanyi Zsolt | Chairman | Buy | 25,344 | $0 |
| 2026-05-04 | White Marvin L | Director | Buy | 25,344 | $0 |
| 2026-05-04 | Fowler Neal Franklin | Director | Buy | 25,344 | $0 |
| 2026-05-04 | Dayal Sujata Tyagi | Director | Buy | 25,344 | $0 |
| 2026-05-04 | FOWLER JOHN D JR | Director | Buy | 25,344 | $0 |
| 2026-05-04 | Zoon Kathryn C | Director | Buy | 25,344 | $0 |
| 2026-05-04 | Katkin Keith | Director | Sell | 15,481 | $128,183 |
| 2026-05-04 | Dayal Sujata Tyagi | Director | Sell | 12,781 | $106,849 |
| 2026-05-04 | DeGolyer Donald W | Director | Sell | 14,527 | $121,446 |
| 2026-05-04 | Zoon Kathryn C | Director | Sell | 16,145 | $134,972 |
| 2026-05-04 | Dayal Sujata Tyagi | Director | Sell | 980 | $8,761 |
| 2026-05-04 | Zoon Kathryn C | Director | Sell | 1,057 | $9,481 |
| 2026-05-04 | DeGolyer Donald W | Director | Sell | 954 | $8,548 |
| 2026-05-01 | Glessner Coleen | EVP, Quality & Ethics, and CPL | Buy | 100,111 | $0 |
| 2026-05-01 | Williams Paul Anthony | SVP, Products Business | Buy | 100,111 | $0 |
| 2026-05-01 | Hartzel William | SVP, Bioservices | Buy | 100,111 | $0 |
| 2026-05-01 | Perl Jessica | SVP, General Counsel, Corp Sec | Buy | 104,282 | $0 |
Source: SEC Form 4 filings · as of 2026-07-02